The company provides services and consulting in the biopharmaceutical field, with a key objective being the early clinical development of new therapeutic approaches and clinical research into the mechanisms of therapies and diseases. In doing so, the company provides its services in partnership with clinical institutions. The company may establish branches in Switzerland and abroad, participate in other companies in Switzerland and abroad, acquire or merge with similar or related companies, and enter into all transactions and conclude contracts that are suitable for promoting the purpose of the company or are directly or indirectly related to it. It may also acquire, manage, encumber and sell properties, intellectual property rights and licenses of all kinds.